MAIA Biotechnology, Inc.
MAIA
$1.33
$0.021.53%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.68M | 3.42M | 2.44M | 3.00M | 2.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.32M | 6.95M | 4.32M | 9.36M | 5.17M |
| Operating Income | -8.32M | -6.95M | -4.32M | -9.36M | -5.17M |
| Income Before Tax | -7.94M | -6.37M | -3.63M | -8.90M | -5.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.94M | -6.37M | -3.63M | -8.90M | -5.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.94M | -6.37M | -3.63M | -8.90M | -5.35M |
| EBIT | -8.32M | -6.95M | -4.32M | -9.36M | -5.17M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.13 | -0.14 | -0.10 | -0.27 | -0.18 |
| Normalized Basic EPS | -0.08 | -0.09 | -0.06 | -0.17 | -0.11 |
| EPS Diluted | -0.13 | -0.14 | -0.10 | -0.27 | -0.18 |
| Normalized Diluted EPS | -0.08 | -0.09 | -0.06 | -0.17 | -0.11 |
| Average Basic Shares Outstanding | 60.79M | 45.21M | 37.19M | 33.20M | 30.30M |
| Average Diluted Shares Outstanding | 60.79M | 45.21M | 37.19M | 33.20M | 30.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |